Antibody of human papilloma virus 45 type L1 protein and preparation method thereof
The invention provides a monoclonal antibody capable of specifically recognizing L1 protein (HPV45L1) and/or VLP (HPV45VLP) of human papilloma virus type 45. The specific monoclonal antibody provided by the invention has no obvious cross reaction with other eight types of HPV (HPV6, 11, 16, 18, 31,...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention provides a monoclonal antibody capable of specifically recognizing L1 protein (HPV45L1) and/or VLP (HPV45VLP) of human papilloma virus type 45. The specific monoclonal antibody provided by the invention has no obvious cross reaction with other eight types of HPV (HPV6, 11, 16, 18, 31, 33, 52 and 58) L1 proteins and/or VLP, and has the advantages of high specificity, high sensitivity, high accuracy and high safety. The method can be used for accurately detecting the content of HPV45 L1 protein and/or VLP bioactive vaccines in vaccine strains, and can be widely applied to clinical detection and vaccine production processes.
本发明提供了一种可特异性识别人乳头瘤病毒45型的L1蛋白(HPV45L1)和/或VLP(HPV45VLP)的单克隆抗体。本发明提供的特异性单克隆抗体与其它8种型别HPV(HPV6、11、16、18、31、33、52、58)L1蛋白和/或VLP无明显交叉反应,具有高特异性,高灵敏度,高准确率、高安全性的优点。可以用于准确检测疫苗种中HPV45的L1蛋白和/或VLP有生物活性疫苗的含量,在临床检测和疫苗生产过程中将会得到广泛应用。 |
---|